title: Comparison of hemagglutination inhibition assay and enzyme immunoassay for determination of mumps and rubella immune status in health care personnel.
abstract: BACKGROUND
  Screening tests are available to determine immunity to vaccine-preventable diseases, such as mumps and rubella. We aimed to define better assay for detecting immune status of health care personnel to vaccine-preventable diseases.
  
  
  METHODS
  Mumps and rubella antibodies of health care personnel at Shimane University Hospital were examined by hemagglutination inhibition assay (HI), comparing with those by enzyme immunoassay (EIA).
  
  
  RESULTS
  A total of 910 sera from health care personnel were tested. There was poor correlation between HI and EIA in detecting mumps antibodies with correlation coefficient values (r) = 0.190 (P < 0.001), but in rubella antibodies HI and EIA were relatively well correlated (r = 0.930, P < 0.001). Seropositivity rate of HI versus EIA was found to be 65.7 versus 93.2, and 89.5 versus 86.5% for mumps and rubella, respectively. As compared with EIA, HI identified sixfold larger seronegative subjects in mumps. Moreover, in mumps, 88.8% of seronegative subjects detected by HI were seropositive by EIA, while 3.7% of seropositive subjects detected by HI were seronegative by EIA. In rubella, 2.1% of seronegative subjects detected by HI were seropositive by EIA, and 1.7% of seropositive by HI was seronegative by EIA.
  
  
  CONCLUSIONS
  Considerable difference between HI and EIA in determining immune status of health care personnel to mumps and rubella suggests beneficial use of EIA for the identification of accurate susceptible personnel who subsequently undergo an effective vaccination programs. Seroprevalence survey of health care personnel by using appropriate assay is essential for prevention and infection control strategies in health care settings.
authors.affiliation: Department of Medical Education and Research, Faculty of Medicine, Shimane University, Izumo, Japan; Infection Control Committee, Faculty of Medicine, Shimane University, Izumo, Japan.
authors.forename: Shunichi
authors.initials: S
authors.lastname: Kumakura
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shibata
authors.forename: Takeshi
authors.initials: T
authors.lastname: Isobe
authors.forename: Masahiro
authors.initials: M
authors.lastname: Hirose
authors.forename: Miki
authors.initials: M
authors.lastname: Ohe
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Nishimura
authors.forename: Keiichi
authors.initials: K
authors.lastname: Onoda
authors.forename: Atsushi
authors.initials: A
authors.lastname: Nagai
authors.forename: Shuhei
authors.initials: S
authors.lastname: Yamaguchi
mesh_terms: D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood*; D005260:Female; D006385:Hemagglutination Inhibition Tests / Q000379:methods*; D006785:Hospitals, University; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009107:Mumps / Q000175:diagnosis / Q000276:immunology*; D010564:Personnel, Hospital; D012409:Rubella / Q000175:diagnosis / Q000276:immunology*; D016036:Seroepidemiologic Studies; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; C040901:rubella antibodies
keywords: enzyme immunoassay; health care personnel; hemagglutination inhibition assay; mumps; rubella; seroprevalence survey
references.citation: Infect Control Hosp Epidemiol. 1998 Jun;19(6):407-63
references.pmid: 9669622
references.citation: J Infect Public Health. 2012 Apr;5(2):127-32
references.pmid: 22541258
references.citation: Infect Control Hosp Epidemiol. 2004 Jul;25(7):591-4
references.pmid: 15301032
references.citation: MMWR Recomm Rep. 1997 Dec 26;46(RR-18):1-42
references.pmid: 9427216
references.citation: J Clin Microbiol. 1979 Jun;9(6):657-64
references.pmid: 387813
references.citation: J Hosp Infect. 2002 Jun;51(2):133-5
references.pmid: 12090801
references.citation: Am J Infect Control. 2006 Nov;34(9):583-7
references.pmid: 17097453